Answers are grounded in this paper and cite their sources.
This study demonstrates enhanced antitumor efficiency through NIR-mediated immunogenic cell death, suggesting novel cancer therapy applications.
The NIR CA DOX NPs can initiate chemo/photothermal therapy with immunogenic cell death (ICD) and parallel mitochondrial/lysosomal damage to augment antitumor efficiency, which provide promising avenue in cancer therapy for preclinical investigation.
No takes yet. Share an insight, caveat, or question.
Geng et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: